Detection of Residual Subclinical Ovarian Carcinoma after Completion of Adjuvant Chemotherapy

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-0523-03PMID 15102671
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 Null Mutations are Associated with a Telomerase Negative Phenotype in Ovarian Carcinoma

  2002cited by this paper
• Impact of second look laparotomy and secondary cytoreductive surgery at second‐look laparotomy in ovarian cancer patients

  2001cited by this paper
• Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.

  1999cited by this paper
• Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.

  1998influential reference
• The role of second-look laparotomy in the long-term survival in ovarian cancer.

  1997cited by this paper
• Telomerase activity in benign and malignant epithelial ovarian tumors.

  1997influential reference
• Survival of women with advanced ovarian cancer and complete pathologic response at second‐look laparotomy

  1996cited by this paper
• Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues.

  1995cited by this paper
• Mammalian telomere dynamics: healing, fragmentation shortening and stabilization.

  1994cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Second-look surgery in the management of epithelial ovarian carcinoma.

  1994cited by this paper
• The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.

  1994cited by this paper
• Telomere length predicts replicative capacity of human fibroblasts.

  1992cited by this paper
• Critical reassessment of second‐look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancer

  1992cited by this paper
• Second-look laparotomy and salvage therapy: a research modality only?

  1992cited by this paper
• Correlation of abdominal ultrasound and computed tomography scans with second‐ or third‐look laparotomy in patients with ovarian carcinoma

  1991cited by this paper
• The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer.

  1991cited by this paper
• Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.

  1991cited by this paper
• Second thoughts about second-look laparotomy in advanced ovarian cancer.

  1990cited by this paper
• Telomeres shorten during ageing of human fibroblasts

  1990cited by this paper
• Second‐look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group study)

  1990cited by this paper
• Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma.

  1988cited by this paper
• Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.

  1988cited by this paper
• A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian cancer.

  1988cited by this paper
• CA 125 serum levels correlated with second-look operations among ovarian cancer patients.

  1986cited by this paper
• Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings.

  1986cited by this paper
• Microscopic disease at second‐look laparotomy in advanced ovarian cancer

  1985cited by this paper
• Second-look laparotomy in ovarian cancer: evaluation of pathologic variables.

  1985cited by this paper
• Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer.

  1985cited by this paper
• Prognosis of surgically determined complete responders in advanced ovarian cancer

  1985cited by this paper
• Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.

  1984cited by this paper
• Survival of Patients Following Secondary Cytoreductive Surgery in Ovarian Cancer

  1983cited by this paper
• A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

  1983cited by this paper
• A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon.

  1973cited by this paper
• STATISTICAL METHODS

  1967cited by this paper

• The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: a prospective clinical study.

  2009cites this paper
• Activity of telomerase in ovarian cancer cells. Clinical implications.

  2009cites this paper
• Molecular targets in gynaecological cancers

  2007cites this paper
• The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.

  2007cites this paper